LEVAQUIN - 50458-165-30 - (levofloxacin)

Alphabetical Index


Drug Information of LEVAQUIN

Product NDC: 50458-165
Proprietary Name: LEVAQUIN
Non Proprietary Name: levofloxacin
Active Ingredient(s): 25    mg/mL & nbsp;   levofloxacin
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION, CONCENTRATE
Coding System: National Drug Codes(NDC)

Labeler Information of LEVAQUIN

Product NDC: 50458-165
Labeler Name: Janssen Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020635
Marketing Category: NDA
Start Marketing Date: 19961220

Package Information of LEVAQUIN

Package NDC: 50458-165-30
Package Description: 30 mL in 1 VIAL, SINGLE-DOSE (50458-165-30)

NDC Information of LEVAQUIN

NDC Code 50458-165-30
Proprietary Name LEVAQUIN
Package Description 30 mL in 1 VIAL, SINGLE-DOSE (50458-165-30)
Product NDC 50458-165
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name levofloxacin
Dosage Form Name INJECTION, SOLUTION, CONCENTRATE
Route Name INTRAVENOUS
Start Marketing Date 19961220
Marketing Category Name NDA
Labeler Name Janssen Pharmaceuticals, Inc.
Substance Name LEVOFLOXACIN
Strength Number 25
Strength Unit mg/mL
Pharmaceutical Classes Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient]

Complete Information of LEVAQUIN


General Information